Showing results (231-240 of 5,042) with videos related to

Sort By:
Pageof 505
Multiple Sclerosis and Related Disorders|October 21, 2022
Epidemiology of familial multiple sclerosis and its comparison to sporadic form in Markazi Province, IranFardin Faraji, Pegah Mohaghegh, Afsoon Talaie
Multiple Sclerosis and Related Disorders|October 21, 2022
Evidence for novel cell defense mechanisms sustained by dimethyl fumarate in multiple sclerosis patients: the HuR/SOD2 cascadeGiulia Mallucci, Nicoletta Marchesi, Lucrezia Irene Maria Campagnoli, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Oligoclonal M bands unveil occult inflammation in multiple sclerosisBonaventura Casanova, Jessica Castillo, Carlos Quintanilla-Bordás, et al.
Multiple Sclerosis and Related Disorders|September 3, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEMJuan I Rojas, Geraldine G Luetic, Carlos Vrech, et al.
Multiple Sclerosis and Related Disorders|September 4, 2022
Multiple sclerosis and migraine: Links, management and implicationsSaloua Mrabet, Mohamad Wafa, Gavin Giovannoni
Multiple Sclerosis and Related Disorders|February 9, 2021
Cross-cultural adaptation, reliability, and validity of the Turkish version of the SymptoMScreenMehmet Özkeskin, Fatih Özden, Serkan Bakırhan, et al.
Multiple Sclerosis and Related Disorders|February 11, 2021
Disability and its association with psychological factors in multiple sclerosis patientsFahimeh Mohaghegh, Mehdi Moghaddasi, Monireh Eslami, et al.
Multiple Sclerosis and Related Disorders|February 13, 2021
Shared breastfeeding & other early multiple sclerosis risk factors: A case-control studyNuha M Alkhawajah, Laith Hussain-Alkhateeb, Yafa A Alshamlan, et al.
Multiple Sclerosis and Related Disorders|February 28, 2021
CLIPPERS syndrome: A case report in a Chinese patient with juxtacortical lesionsHaiqiang Jin, Yuhan Gao, Qianshuo Lu, et al.
Multiple Sclerosis and Related Disorders|February 21, 2021
Reduction of the risk of PML in natalizumab treated MS patients in Sweden: An effect of improved PML risk surveillanceStina Kågström, Anna Fält, Anders Berglund, et al.
Pageof 505